查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1632574

全球臨床實驗管理服務市場：市場規模、佔有率和趨勢分析（按服務、適應症、最終用途、地區和細分，2025-2030 年）

Clinical Trial Management Services Market Size, Share & Trends Analysis Report By Services, By Indication, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 145 Pages | 商品交期: 2-10個工作天內

價格

臨床實驗管理服務市場的成長與趨勢：

根據Grand View Research, Inc.的新報告，全球臨床實驗管理服務市場規模預計到2030年將達到538.5億美元。

預計 2025 年至 2030 年期間市場複合年成長率為 8.26%。臨床實驗活動外包趨勢日益成長、尖端治療研發活性化以及臨床實驗的全球化是推動市場成長的一些主要因素。

在過去 20 年中，臨床實驗的數量顯著增加。其背景是，對療效較高的新型藥品的需求不斷增加，以及尖端醫療技術的普及。根據 clinical trials.gov 的數據，2020 年的臨床實驗總數為 325,773 項，而截至 2022 年 4 月，今年的臨床實驗總數超過 410,903 項。

我們的臨床臨床實驗管理服務包括臨床監測、資料管理、現場監測和醫學寫作服務，既經濟高效又節省時間。它們還能協調各中心之間的臨床資料並降低失敗率。此外，雲端運算、人工智慧（AI）、巨量資料處方、預測分析、醫療物聯網和行動技術等數位技術的整合仍在大力發展。這些技術在提高生產力的同時加快臨床實驗的步伐，顯示出巨大的潛力。

新冠肺炎疫情對市場產生了重大影響。 COVID-19 疫情對市場產生了重大影響，導致對開展臨床實驗試驗和限制現場監測訪問的替代解決方案的需求出乎意料的緊迫。為了限制 COVID-19 的傳播並保持臨床研究的正常進行，研究人員已經轉向遠端臨床實驗監控服務和平台。例如，2020 年佛羅倫薩的一項調查發現，超過 60% 的臨床實驗地點和臨床實驗申辦方表示，他們對臨床研究遠端站點監控解決方案的接受度超過 50%。

臨床實驗管理服務市場：分析概述

  • 2024 年臨床實驗試驗監測領域將主導臨床實驗管理服務業。
  • 2024 年，腫瘤學領域將主導臨床實驗管理服務業。成長的主要驅動力是對癌症研發的投入增加、癌症發生率的上升、對個人化藥物治療的需求增加，以及腫瘤學領域創新發展的激增。
  • 2024 年的臨床實驗管理服務業將以製藥業為主導。這在很大程度上歸功於過去二十年來研發投入和開發新藥的增加。
  • 北美主導臨床實驗管理服務市場。對新治療方法和新藥的需求導致全部區域臨床實驗數量激增。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

第3章臨床實驗管理服務市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 臨床實驗管理服務市場：分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19影響分析

第 4 章臨床實驗管理服務市場：按服務分類的估計和趨勢分析

  • 細分儀表板
  • 全球臨床實驗管理服務市場：按服務進行變化分析
  • 全球臨床實驗管理服務市場規模與趨勢分析（按服務分類）（2018-2030 年）
  • 臨床實驗監測
  • 監管提交
  • 臨床實驗資料管理
  • 醫學寫作
  • 網站管理
  • 計劃管理
  • 其他

第 5 章臨床實驗管理服務市場：按適應症進行的估計和趨勢分析

  • 細分儀表板
  • 全球臨床實驗管理服務市場：依適應症進行變化分析
  • 全球臨床實驗管理服務市場規模與趨勢分析（按適應症分類）（2018-2030 年）
  • 自體免疫/炎症
  • 疼痛管理
  • 腫瘤學
  • 中樞神經系統疾病
  • 糖尿病
  • 肥胖
  • 心血管
  • 其他

第6章臨床實驗管理服務市場：依最終用途的估計與趨勢分析

  • 細分儀表板
  • 全球臨床實驗管理服務市場：按最終用途進行的變化分析
  • 全球臨床實驗管理服務市場規模和趨勢分析（按最終用途）（2018-2030 年）
  • 藥品
  • 生物製藥
  • 醫療設備

第7章臨床實驗管理服務市場：區域估計與趨勢分析

  • 區域市場儀表板
  • 全球市場概況：按地區
  • 市場規模預測及趨勢分析（2018-2030年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 市場參與企業分類
    • 市場領導
    • 新興企業
  • 公司市場地位分析
  • 公司簡介
    • CTI Clinical Trial &Consulting
    • Charles River Laboratories
    • Medpace Holdings, Inc.
    • Wuxi Apptec
    • SGS Societe Generale de Surveillance SA
    • Laboratory Corporation of America Holdings
    • IQVIA, Inc.
    • Syneous Health
    • Atlantic Research Group
    • ICON Plc
Product Code: GVR-4-68039-993-8

Clinical Trial Management Services Market Growth & Trends:

The global clinical trial management services market size is anticipated to reach USD 53.85 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.26% from 2025 to 2030. The increasing trend of outsourcing clinical trial activities, the rise in research and development of advanced therapies, and the globalization of clinical trials are a few key factors driving the growth of the market.

The number of clinical trials has significantly increased in the past two decades. This is due to the rising need for novel pharmaceutical products with improved efficacy as well as the increasing penetration of cutting-edge medical technologies. According to Clinical trials.gov, the total number of clinical trials accounted for 325,773 in 2020, whereas, as of April 2022, the number of clinical trials this year totaled more than 410,903.

Clinical trial management services such as clinical monitoring, data management, site monitoring, and medical writing service are cost-effective and time-saving. These also harmonize clinical data across sites and failure rates. Furthermore, the integration of digital technologies, including cloud computing, Artificial Intelligence (AI), big data prescriptive, and predictive analytics, the Internet of Medical Things, and mobile technology remain major developments on the horizon. These technologies have shown great promise in improving productivity while accelerating the pace of clinical trials.

The COVID-19 pandemic significantly impacted the market. It created an unexpected urgency for alternative solutions to clinical trial execution, limiting on-site monitoring visits. It prompted researchers to use remote clinical trial monitoring services and platforms to reduce the spread of the COVID-19 infection as well as to simultaneously function in clinical research. For instance, according to the Florence survey in 2020, more than 60% of clinical study sites and clinical trial sponsors stated more than 50% acceptance of remote site monitoring solutions for clinical research.

Clinical Trial Management Services Market Report Highlights:

  • The clinical trial monitoring segment dominated the clinical trial management services industry in 2024.
  • The oncology segment dominated the clinical trial management services industry in 2024. The rise in oncology R&D investments, the increasing cancer incidences, and the growing demand for personalized medications, coupled with a surge in innovative developments in the field of oncology, are the key factors driving the growth.
  • The pharmaceuticals segment dominated the clinical trial management services industry in 2024. This can be largely attributed to the rise in R&D investments and the development of new drugs over the past two decades.
  • North America dominated the clinical trial management services market. The demand for new therapies and drugs has led to a surge in clinical trials across the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates and Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Purchased Database
    • 1.3.3. GVR's Internal Database
    • 1.3.4. Secondary Sources
    • 1.3.5. Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
    • 1.5.1. Region Wise Market: Base Estimates
    • 1.5.2. Global Market: CAGR Calculation
  • 1.6. Model Details
    • 1.6.1. Commodity Flow Analysis (Model 1)
    • 1.6.2. Value-Chain-Based Sizing & Forecasting (Model 2)
    • 1.6.3. QFD Model Sizing & Forecasting (Model 3)
    • 1.6.4. Bottom-Up Approach (Model 4)
  • 1.7. List of Secondary Sources
  • 1.8. List of Abbreviations
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Clinical Trial Management Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing technological advancement in the clinical trial monitoring services
      • 3.2.1.2. Rise in R&D expenditure by pharmaceutical and biopharmaceutical companies
      • 3.2.1.3. Growth in the number of outsourced projects related to clinical trial management services
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with clinical trial management services
      • 3.2.2.2. Stringent regulatory policies for clinical trial management services
  • 3.3. Clinical Trial Management Services Market: Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Management Services Market: Services Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Clinical Trial Management Services Market, Services Movement Analysis
  • 4.3. Global Clinical Trial Management Services Market Size & Trend Analysis, by Services, 2018 to 2030 (USD Million)
  • 4.4. Clinical Trial Monitoring
    • 4.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.5. Regulatory Submissions
    • 4.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.6. Clinical Trial Data Management
    • 4.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.7. Medical Writing
    • 4.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.8. Site Management
    • 4.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.9. Project Management
    • 4.9.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 5. Clinical Trial Management Services Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Clinical Trial Management Services Market, Indication Movement Analysis
  • 5.3. Global Clinical Trial Management Services Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 5.4. Autoimmune/Inflammation
    • 5.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.5. Pain Management
    • 5.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.6. Oncology
    • 5.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.7. CNS Conditions
    • 5.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.8. Diabetes
    • 5.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.9. Obesity
    • 5.9.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.10. Cardiovascular
    • 5.10.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 6. Clinical Trial Management Services Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Clinical Trial Management Services Market, End Use Movement Analysis
  • 6.3. Global Clinical Trial Management Services Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceuticals
    • 6.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 6.5. Biopharmaceuticals
    • 6.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 6.6. Medical Devices
    • 6.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 7. Clinical Trial Management Services Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Global Regional Market Snapshot
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.4. North America
    • 7.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Scenario
      • 7.4.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Scenario
      • 7.4.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Scenario
      • 7.4.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Scenario
      • 7.5.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Scenario
      • 7.5.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Scenario
      • 7.5.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Scenario
      • 7.5.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Scenario
      • 7.5.6.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Scenario
      • 7.5.7.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Scenario
      • 7.5.8.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Scenario
      • 7.5.9.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Scenario
      • 7.6.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.3. Japan
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Scenario
      • 7.6.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Scenario
      • 7.6.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Scenario
      • 7.6.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Scenario
      • 7.6.6.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Scenario
      • 7.6.7.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Scenario
      • 7.7.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Scenario
      • 7.7.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Scenario
      • 7.8.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Scenario
      • 7.8.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Scenario
      • 7.8.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Scenario
      • 7.8.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
    • 8.1.1. Market Leaders
    • 8.1.2. Emerging Players
  • 8.2. Company Market Position Analysis
  • 8.3. Company Profiles
    • 8.3.1. CTI Clinical Trial & Consulting
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Charles River Laboratories
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Medpace Holdings, Inc.
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Wuxi Apptec
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. SGS Societe Generale de Surveillance SA
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Laboratory Corporation of America Holdings
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. IQVIA, Inc.
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Syneous Health
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Atlantic Research Group
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. ICON Plc
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 4 Global Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 5 Global Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 6 Global Clinical Trial Management Services, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 9 North America Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 10 North America Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 12 U.S. Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 13 U.S. Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 14 Canada Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 15 Canada Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 16 Canada Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Mexico Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 18 Mexico Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 19 Mexico Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Europe Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 22 Europe Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 23 Europe Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 24 Germany Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 25 Germany Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 26 Germany Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 27 UK Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 28 UK Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 29 UK Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 30 France Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 31 France Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 32 France Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Italy Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 34 Italy Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 35 Italy Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 36 Spain Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 37 Spain Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 38 Spain Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 39 Denmark Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 40 Denmark Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 41 Denmark Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Sweden Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 43 Sweden Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 44 Sweden Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Norway Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 46 Norway Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 47 Norway Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 52 China Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 53 China Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 54 China Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 55 Japan Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 56 Japan Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 57 Japan Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 58 India Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 59 India Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 60 India Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 61 South Korea Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 62 South Korea Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 63 South Korea Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 64 Australia Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 65 Australia Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 66 Australia Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Thailand Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 68 Thailand Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 69 Thailand Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 70 Latin America Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 72 Latin America Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 73 Latin America Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 74 Brazil Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 75 Brazil Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 76 Brazil Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 78 Argentina Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 79 Argentina Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Clinical Trial Management Services, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 85 South Africa Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 86 South Africa Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 90 UAE Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 91 UAE Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 92 UAE Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Clinical Trial Management Services, by Services, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Clinical Trial Management Services, by Indication, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Clinical Trial Management Services, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Clinical Trial Management Services, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 Porter's Five Forces Analysis
  • Fig. 10 PESTEL Analysis
  • Fig. 11 Regional Marketplace: Key Takeaways
  • Fig. 12 Global Clinical Trial Management Services, for Clinical Trial Monitoring, 2018 - 2030 (USD Million)
  • Fig. 13 Global Clinical Trial Management Services, for Regulatory Submissions, 2018 - 2030 (USD Million)
  • Fig. 14 Global Clinical Trial Management Services, for Clinical Trial Data Management, 2018 - 2030 (USD Million)
  • Fig. 15 Global Clinical Trial Management Services, for Medical Writing, 2018 - 2030 (USD Million)
  • Fig. 16 Global Clinical Trial Management Services, for Site Management, 2018 - 2030 (USD Million)
  • Fig. 17 Global Clinical Trial Management Services, for Project Management, 2018 - 2030 (USD Million)
  • Fig. 18 Global Clinical Trial Management Services, for Others, 2018 - 2030 (USD Million)
  • Fig. 19 Global Clinical Trial Management Services, for Autoimmune/Inflammation, 2018 - 2030 (USD Million)
  • Fig. 20 Global Clinical Trial Management Services, for Pain Management, 2018 - 2030 (USD Million)
  • Fig. 21 Global Clinical Trial Management Services, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 22 Global Clinical Trial Management Services, for CNS Conditions, 2018 - 2030 (USD Million)
  • Fig. 23 Global Clinical Trial Management Services, for Diabetes, 2018 - 2030 (USD Million)
  • Fig. 24 Global Clinical Trial Management Services, for Obesity, 2018 - 2030 (USD Million)
  • Fig. 25 Global Clinical Trial Management Services, for Cardiovascular, 2018 - 2030 (USD Million)
  • Fig. 26 Global Clinical Trial Management Services, for Others, 2018 - 2030 (USD Million)
  • Fig. 27 Global Clinical Trial Management Services, for Pharmaceuticals, 2018 - 2030 (USD Million)
  • Fig. 28 Global Clinical Trial Management Services, for Biopharmaceuticals, 2018 - 2030 (USD Million)
  • Fig. 29 Global Clinical Trial Management Services, for Medical Devices, 2018 - 2030 (USD Million)
  • Fig. 30 Regional Outlook, 2023 & 2030
  • Fig. 31 North America Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 US Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Canada Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Europe Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Germany Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 UK Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 France Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Italy Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Spain Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Norway Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Japan Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 China Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 India Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Australia Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 UAE Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait Clinical Trial Management Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)